• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白C-I、转甲状腺素蛋白和载脂蛋白C-III在胃癌中的诊断价值

Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer.

作者信息

Wang Min, Wang Jing, Jiang Honggang

机构信息

Department of Gastrointestinal Surgery, The First Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314000, P.R. China.

Teaching-research Office of General Practice, Hangzhou Medical College, Hangzhou, Zhejiang 310000, P.R. China.

出版信息

Oncol Lett. 2019 Mar;17(3):3227-3232. doi: 10.3892/ol.2019.9957. Epub 2019 Jan 22.

DOI:10.3892/ol.2019.9957
PMID:30867753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6396204/
Abstract

Diagnostic value of apolipoprotein C-I (ApoC-I), transthyretin (TTR) and ApoC-III in gastric cancer were evaluated. Retrospective analysis methods were used to collect 60 patients with gastric cancer first diagnosed in The First Affiliated Hospital of Jiaxing University. There were 60 patients with chronic atrophic gastritis in the benign lesion group and 60 healthy individuals in the control group. The expression levels of serum ApoC-I, TTR and ApoC-III was detected by enzyme-linked immunosorbent assay. Differences existed in the expression levels of ApoC-I, TTR and ApoC-III in the gastric cancer group, benign lesion group and control group (P<0.001), with the expression levels of ApoC-I, TTR and ApoC-III in the gastric cancer group being lower than that of the benign lesion group (P<0.05), and the expression levels of ApoC-I, TTR and ApoC-III in the benign lesion group being lower than that of the control group (P<0.05). The expression levels of ApoC-I, TTR and ApoC-III in the gastric cancer group were to a certain degree correlated with the clinical stage, lymph node metastasis and differentiation of patients in the gastric cancer group (P<0.05). The specificity and negative predictive value of combined detection were proven to be higher than the separate detection of the three factors (P<0.05). The detection of serum ApoC-I, TTR and ApoC-III was of great significance in the diagnosis of gastric cancer and the estimation of its severity. The method of combined detection is worth a further in-depth study as it could improve the specificity of diagnosis and have a higher negative predictive value.

摘要

评估载脂蛋白C-I(ApoC-I)、转甲状腺素蛋白(TTR)和载脂蛋白C-III在胃癌中的诊断价值。采用回顾性分析方法,收集嘉兴学院附属第一医院首次诊断的60例胃癌患者。良性病变组有60例慢性萎缩性胃炎患者,对照组有60例健康个体。采用酶联免疫吸附测定法检测血清ApoC-I、TTR和ApoC-III的表达水平。胃癌组、良性病变组和对照组中ApoC-I、TTR和ApoC-III的表达水平存在差异(P<0.001),胃癌组中ApoC-I、TTR和ApoC-III的表达水平低于良性病变组(P<0.05),良性病变组中ApoC-I、TTR和ApoC-III的表达水平低于对照组(P<0.05)。胃癌组中ApoC-I、TTR和ApoC-III的表达水平与胃癌患者的临床分期、淋巴结转移及分化程度在一定程度上相关(P<0.05)。联合检测的特异性和阴性预测值被证明高于三种因子单独检测(P<0.05)。血清ApoC-I、TTR和ApoC-III的检测对胃癌的诊断及其严重程度的评估具有重要意义。联合检测方法值得进一步深入研究,因为它可以提高诊断的特异性并具有更高的阴性预测值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1585/6396204/88463cdaa1db/ol-17-03-3227-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1585/6396204/88463cdaa1db/ol-17-03-3227-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1585/6396204/88463cdaa1db/ol-17-03-3227-g00.jpg

相似文献

1
Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer.载脂蛋白C-I、转甲状腺素蛋白和载脂蛋白C-III在胃癌中的诊断价值
Oncol Lett. 2019 Mar;17(3):3227-3232. doi: 10.3892/ol.2019.9957. Epub 2019 Jan 22.
2
Evaluation of serum apolipoprotein C-III concentration by enzyme-linked immunosorbent assay and its higher concentration in cows during midlactation than during the nonlactating stage.用酶联免疫吸附测定法评估血清载脂蛋白C-III浓度及其在奶牛泌乳中期的浓度高于非泌乳期。
Am J Vet Res. 1998 Nov;59(11):1358-63.
3
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.载脂蛋白C-III,男性冠心病风险的强判别指标,也是两性代谢综合征的决定因素。
Atherosclerosis. 2003 May;168(1):81-9. doi: 10.1016/s0021-9150(03)00025-x.
4
High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals.载脂蛋白 C-III 的高密度脂蛋白与一般健康个体的颈动脉内膜中层厚度有关。
Atherosclerosis. 2018 Feb;269:92-99. doi: 10.1016/j.atherosclerosis.2017.12.029. Epub 2018 Jan 2.
5
Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125.评估人附睾蛋白4(HE4)和甲状腺素运载蛋白(TTR)用于卵巢癌诊断:与癌抗原125(CA-125)的比较
J Gynecol Obstet Hum Reprod. 2018 Jun;47(6):227-230. doi: 10.1016/j.jogoh.2018.03.010. Epub 2018 Mar 30.
6
Concentrations of apolipoprotein C-III in healthy cows during the peripartum period and cows with milk fever.围产期健康奶牛和患乳热奶牛的载脂蛋白C-III浓度。
J Vet Med Sci. 2001 Jun;63(6):597-601. doi: 10.1292/jvms.63.597.
7
Apolipoproteins C-II and C-III as nutritional markers unaffected by inflammation.载脂蛋白 C-II 和 C-III 作为不受炎症影响的营养标志物。
Clin Chim Acta. 2018 Jun;481:225-230. doi: 10.1016/j.cca.2018.03.004. Epub 2018 Mar 11.
8
Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.阿托伐他汀降低2型糖尿病患者含载脂蛋白B脂蛋白和高密度脂蛋白中的载脂蛋白C-III:一种降低血浆甘油三酯的潜在机制。
Diabetes Care. 2004 Jun;27(6):1358-64. doi: 10.2337/diacare.27.6.1358.
9
Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk.载脂蛋白 C-III 与高密度脂蛋白亚类及其与糖尿病风险的关系。
Am J Epidemiol. 2017 Sep 15;186(6):736-744. doi: 10.1093/aje/kwx143.
10
Higher Apolipoprotein C-III Levels in Cerebrospinal Fluid are Associated with Slower Cognitive Decline in Mild Cognitive Impairment.脑脊液中载脂蛋白 C-III 水平升高与轻度认知障碍认知衰退速度较慢有关。
J Alzheimers Dis. 2019;67(3):961-969. doi: 10.3233/JAD-181096.

引用本文的文献

1
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis.骨髓中原发性骨髓纤维化伴纤维化前期与特发性血小板增多症的多组学差异。
Clin Exp Med. 2024 Jul 8;24(1):154. doi: 10.1007/s10238-024-01350-y.
2
The Role of Apolipoproteins in the Commonest Cancers: A Review.载脂蛋白在最常见癌症中的作用:综述
Cancers (Basel). 2023 Nov 24;15(23):5565. doi: 10.3390/cancers15235565.
3
Apolipoproteins: New players in cancers.载脂蛋白:癌症中的新角色。

本文引用的文献

1
Identification of key pathways and biomarkers in sorafenib-resistant hepatocellular carcinoma using bioinformatics analysis.利用生物信息学分析鉴定索拉非尼耐药肝细胞癌中的关键通路和生物标志物
Exp Ther Med. 2018 Sep;16(3):1850-1858. doi: 10.3892/etm.2018.6427. Epub 2018 Jul 9.
2
Serum transthyretin level is associated with prognosis of patients with gastric cancer.血清甲状腺素运载蛋白水平与胃癌患者的预后相关。
J Surg Res. 2018 Jul;227:145-150. doi: 10.1016/j.jss.2018.02.035. Epub 2018 Mar 15.
3
Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro.
Front Pharmacol. 2022 Nov 25;13:1051280. doi: 10.3389/fphar.2022.1051280. eCollection 2022.
4
Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers.构建血浆蛋白质 2DE 图谱:潜在肿瘤标志物的一个方面。
Int J Mol Sci. 2022 Sep 21;23(19):11113. doi: 10.3390/ijms231911113.
5
Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study.载脂蛋白 C1 血清水平作为胶质母细胞瘤患者肿瘤标志物的可行性:一项初步研究。
Sci Rep. 2022 Oct 10;12(1):16981. doi: 10.1038/s41598-022-21216-1.
6
Apolipoprotein: prospective biomarkers in digestive tract cancer.载脂蛋白:消化道癌症的潜在生物标志物。
Transl Cancer Res. 2020 May;9(5):3712-3720. doi: 10.21037/tcr-19-2106.
7
Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs.脂蛋白与癌症:高密度脂蛋白胆固醇、低密度脂蛋白胆固醇和降胆固醇药物的作用。
Biochem Pharmacol. 2022 Feb;196:114654. doi: 10.1016/j.bcp.2021.114654. Epub 2021 Jun 12.
8
Discovery and Evaluation of Protein Biomarkers as a Signature of Wellness in Late-Stage Cancer Patients in Early Phase Clinical Trials.在早期临床试验中发现和评估蛋白质生物标志物作为晚期癌症患者健康状况的特征
Cancers (Basel). 2021 May 18;13(10):2443. doi: 10.3390/cancers13102443.
9
Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review.鉴定适用于低发人群的上消化道癌早期检测的新型生物标志物:系统评价。
Adv Ther. 2021 Feb;38(2):793-834. doi: 10.1007/s12325-020-01571-z. Epub 2020 Dec 11.
10
Expression of apolipoprotein C1 in clear cell renal cell carcinoma: An oncogenic gene and a prognostic marker.载脂蛋白 C1 在肾透明细胞癌中的表达:一种致癌基因和一个预后标志物。
Kaohsiung J Med Sci. 2021 May;37(5):419-426. doi: 10.1002/kjm2.12328. Epub 2020 Dec 10.
载脂蛋白C1在体外促进前列腺癌细胞增殖。
J Biochem Mol Toxicol. 2018 May 2;32(7):e22158. doi: 10.1002/jbt.22158.
4
Impact of Malnutrition After Gastrectomy for Gastric Cancer on Long-Term Survival.胃癌胃切除术后营养不良对长期生存的影响。
Ann Surg Oncol. 2018 Apr;25(4):974-983. doi: 10.1245/s10434-018-6342-8. Epub 2018 Jan 31.
5
Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.使用基于质谱的蛋白质组学方法对胰腺癌生物标志物进行大规模临床验证。
Oncotarget. 2017 Jun 27;8(26):42761-42771. doi: 10.18632/oncotarget.17463.
6
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胃癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v38-v49. doi: 10.1093/annonc/mdw350.
7
Diagnostic accuracy of 18F-FDG PET/CT for detecting synchronous advanced colorectal neoplasia in patients with gastric cancer.18F-FDG PET/CT对胃癌患者同步性进展期结直肠肿瘤的诊断准确性
Medicine (Baltimore). 2016 Sep;95(36):e4741. doi: 10.1097/MD.0000000000004741.
8
[Correlation analysis between glycolipids metabolism and clinicopathologic features in patients with gastric cancer].[胃癌患者糖脂代谢与临床病理特征的相关性分析]
Zhonghua Yi Xue Za Zhi. 2016 Aug 23;96(32):2545-7. doi: 10.3760/cma.j.issn.0376-2491.2016.32.006.
9
Is transthyretin a good marker of nutritional status?转甲状腺素蛋白是营养状况的良好标志物吗?
Clin Nutr. 2017 Apr;36(2):364-370. doi: 10.1016/j.clnu.2016.06.004. Epub 2016 Jun 20.
10
Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry.基于质谱分析的血清载脂蛋白C-I在三阴性乳腺癌中的诊断及预后意义
Cancer Biol Ther. 2016 Jun 2;17(6):635-47. doi: 10.1080/15384047.2016.1156262. Epub 2016 Jun 3.